BiotechTube
Home/Nkarta/Andrea van Elsas, Ph.D.
AV

Andrea van Elsas, Ph.D.

Chief Scientific Officer, Autoimmune

Nkarta

Therapeutic Areas

Autoimmune DiseasesOncology

Nkarta Pipeline

DrugIndicationPhase
NKX019Lupus NephritisPhase 1
NKX101Acute Myeloid Leukemia / Higher-Risk MDSPhase 1

Leadership Team at Nkarta

PJ
Paul J. Hastings
Chief Executive Officer & Chairman
JR
James R. Trager, Ph.D.
Chief Scientific Officer
DR
David R. Shook, M.D.
Chief Medical Officer
NR
Nigel R. Parker, CPA
Chief Financial Officer
RG
Randy G. Robinson
Chief Commercial Officer, Autoimmune
View full Nkarta profile